source
- Europe’s drug pricing split: UK leans pro‑industry while Germany eyes cuts and higher feesEuropean nations are feeling mounting pressure to rein in drug prices, a trend that is reshaping the market for both manufacturers and patients across the continent. In the United Kingdom, lobbyin…
- Sanofi halts rare disease trial as Parabilis launches record biotech IPO amid European pricing debateSanofi announced it is stopping a Phase 3 trial of its experimental drug riliprubart in a rare autoimmune disease after an interim analysis showed the treatment did not work. The pause adds to rec…